Investment Column: Rising losses at Chiroscience
Tuesday 29 April 1997
The company has not been shy about selling the virtues of its drugs pipeline, which includes a look-alike version of British Biotech's Marimastat anti- cancer drug and a non-steroidal asthma drug based on so-called PDE IV inhibitors. It is already claiming its matrix metalloproteinase drug for cancer and its asthma treatment offer reduced side effects. Yet the comparisons are being made against drugs some years away from the market, while the company's own treatments will only start to be tested in humans later this year.
More tangible evidence of progress came yesterday with news the ChiroTech subsidiary had become the first part of Chiroscience to break into the black, recording profits of pounds 1.2m last year. The business merely provides intermediate chemicals, admittedly sophisticated ones, to other pharmaceutical companies.
Chiroscience is promising an update next month on progress at Darwin Molecular, the US drug discovery operation acquired last year in another marketing coup, bringing in as it did Microsoft founder Bill Gates as a shareholder.
But more important is the outlook for Levobupivacaine, a more chemically pure version of an anaesthetic produced by Astra. That is on course to be submitted for approval in Europe this year.
But with so much riding on that single product, the shares remain speculative. A further cash call is also a real prospect, given that operating losses are set to rise to pounds 25m this year.
- 1 Notting Hill Carnival: Woman shares selfie after being ‘punched in face for telling man to stop groping her’
- 2 Keira Knightley topless: Usually conservative actress does own take on #Freethenipple campaign for Interview Magazine
- 3 Daily Show's Jon Stewart destroys Fox News for its Ferguson coverage
- 4 When elitism grips the top of British society to this extent, there is only one answer: abolish private schools
- 5 Brother and sister, Christopher Buckner and Timothy Savoy, arrested for 'committing incest after watching 'The Notebook''
Ashya King missing: Police hunt five-year-old boy with brain tumour snatched from Southampton hospital by his parents
Keira Knightley topless: Usually conservative actress does own take on #Freethenipple campaign for Interview Magazine
YouTube video posted by Isis militants shows 'execution of 250 Syrian soldiers'
Botched ice bucket challenge leaves man critically injured after plane drops hundreds of gallons of water
Papua New Guinea Mount Tavurvur volcano eruption sees international flights diverted
Exclusive: We share blame for creating 'jihad generation', says Muslim strategist
Robin Williams Emmys tribute led by Billy Crystal criticised for including 'racist' joke about Muslim woman
The Rotherham child abuse scandal is a tale of apologists, misogyny and double standards
Scottish independence TV debate: Pumped-up Alex Salmond bounces back in bruising second round against Alistair Darling
Do you realise just how foolish the UK looks?
Ukip Douglas Carswell defection: Tory MP jumps ship to join Nigel Farage
- < Previous
- Next >
iJobs Money & Business
£450 - £500 per day: Orgtel: SAS Business Analyst, London, Banking, Credit Ris...
£32000 - £38000 Per Annum Bonus, Life Insurance + Other Benefits: Clearwater P...
£200 - £250 per day + competitive: Orgtel: KYC Analyst, Key Banking Client, Bi...
£400 - £500 per day: Orgtel: Test Manager - Banking - West Yorkshire - £400-£5...